Randomized study for treatment of COVID pneumonia uses cystic fibrosis drug dornase alfa
Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory ...
Jul 28, 2020
0
6